Moon Capital Management, LLC, an investment management company, released its second quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 500 index rebounded in the second ...

In the latest trading session, DaVita HealthCare (DVA) closed at $236.97, marking a +1.26% move from the previous day. This ...

Unfortunately, DaVita’s growth algorithm has become more challenging. After decades of expansion, total dialysis treatment ...

"We delivered strong financial results ahead of our expectations with outperformance from each element of our U.S. dialysis trilogy; treatment volume, revenue per treatment and cost per treatment." ...

Shares of DaVita Inc. DVA rallied 1.36% to $237.28 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.89% to 7,509.20 and the ...

Shares of DaVita Inc. DVA shed 1.21% to $234.10 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0.19% to 7,443.28 and Dow Jones ...

DaVita HealthCare (DVA) ended the recent trading session at $234.01, demonstrating a +1.04% change from the preceding day's closing price. The stock exceeded the S&P 500, which registered a loss of 0.

DaVita says its Novi dialysis center will resume patient services July 2 after third-party reviews of equipment and water quality found no problems, as a state investigation into a patient death and ...

UnitedHealth strikes a $4.9 billion deal to acquire the DaVita Medical Group unit from kidney dialysis firm DaVita in an all-cash transaction. Last month, DMG posted a $5 million operating loss in the ...

DaVita Novi will reopen July 2 after an investigation into the death of a patient and sicknesses of several others treated at the center.